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BACKGROUND The Trypanosoma cruzi infection endemic in Latin America has now spread to several countries across four 
continents; this endemic involves triatomine vector-free protists. We hypothesised that the sexual transmission of T. cruzi 
contributes to the ongoing spread of Chagas disease.
OBJECTIVES A short-term longitudinal study was conducted to evaluate this hypothesis.
METHODS The study population comprised 109 subjects from four families, among whom 21 had been diagnosed with acute 
Chagas disease by direct parasitological analysis. Blood mononuclear cells and serum samples were obtained from each study 
subject once per year for three consecutive years. Enzyme-linked immunosorbent assay (ELISA) and indirect immunofluorescence 
serological examinations were used to detect specific T. cruzi antibodies. Polymerase chain reaction of T. cruzi DNA revealed 
188-nucleotide bands, which hybridised to a specific radiolabelled probe and were confirmed by cloning and sequencing.
RESULTS Three independent assessments at different time points revealed T. cruzi nuclear DNA footprints in 76% (83/109) of 
the study population with active infection. In contrast, the ELISA and indirect immunofluorescence assays detected the T. cruzi 
antibody in 28.4% (31/109) of the study samples. Moreover, the semen from 82.6% (19/23) of subjects people revealed harboured 
the 188- bp base pair T. cruzi footprint. Interestingly, the ejaculates of nuclear DNA-positive Chagas patient transmitted the 
T. cruzi upon peritoneal injection or infusion in the vagina of mice, and amastigotes were detected in the skeletal muscle, 
myocardium, vas deferens, and uterine tube.
MAIN CONCLUSIONS T. cruzi infections can be transmitted from females or males to naïve mates through intercourse, and 
progeny showed discrepancies between the ratios of nuclear DNA footprints and specific antibody that can be explained by 
the tolerance attained during early embryo growth. Additional studies are needed to develop drugs to eradicate the infections. 
Additionally, the importance of a vigorous education, information, and communication program to prevent sexually transmitted 
Chagas disease in humans cannot be underemphasised.
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The highly diversified Trypanosoma cruzi protozoan 
of the Order Kinetoplastida and family Trypanosoma-
tidae is important in the medical and veterinary fields 
(Chagas 1909). American Trypanosomiasis, widely 
known as Chagas disease, is caused by T. cruzi infec-
tion and affects mammals. This disease is enzootic from 
the 42nd parallel north in Northern California down to 
the 42nd parallel south in the Chubut province of South-
ern Argentina, where the hematophagous triatomines 
(Reduviid: Triatominae) bugs agents transmit T. cruzi to 
hundreds of species belonging to eight classes of mam-
mals. Amerindians readily acquired T. cruzi from insect 
vectors that fed on domesticated mammals, and the in-
fections were then passed on to European and African 
settlers and their descendants (Teixeira et al. 2011a). In 
the past century, these infections have become hyper-
endemic to Latin America and are now present on five 
continents (Schmunis & Yadon 2010, Albajar-Viñas & 
Jannin 2011, Pérez-Molina et al. 2012). Acute T. cruzi in-
fections are often either asymptomatic or oligosymptom-
atic and self-limited, but chronically infected people may 
develop Chagas disease, which is now a leading cause of 
heart failure in the Western hemisphere. Chagas disease 
is a clinical condition observed in approximately 30% of 
people infected with T. cruzi; in most cases, the disease 
attacks the heart (94.5%), but it can also cause megacolon 
and megaesophagus in the digestive system. Currently, 
there is no effective treatment for T. cruzi infection, and 
the available treatments for the late manifestations of 
Chagas disease are unsatisfactory (Lauria-Pires et al. 
2000, Teixeira et al. 2011a, Morillo et al. 2015).
The endemic nature of T. cruzi infection has been as-
sociated with various modes of transmission (Coura et al. 
2002). The ancient oral route, insect vector blood-borne 
infection, blood transfusion, organ transplantation, and 
accidental transmission in the hospital and research labo-
ratories have contributed to the prevalence of exogenous 
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infections in the human population (Teixeira et al. 2001, 
Pérez-Molina et al. 2012). Additionally, T. cruzi transmis-
sion from a mother to her offspring through the placenta 
is the only currently recognised endogenous source of 
infection. Murcia et al. (2013) found that transplacental 
transmission of T. cruzi from mothers to offspring occurs 
in approximately 13.8% of pregnancies.
Early studies (Chagas 1909, Vianna 1911) suggested 
that T. cruzi can spread via sexual transmission. Experi-
mental studies in laboratory animals revealed the pres-
ence of T. cruzi amastigote nests in the seminiferous 
tubes, epididymis, and vas deferens, as well as in the 
uterus, tubes, and ovary theca cells of acutely infected 
mice (Carvalho et al. 2009). Interestingly, the T. cruzi 
life cycle was observed in the ejaculate of a chagasic 
mouse. Sexual transmission of the parasites from T. cru-
zi-infected mice to naïve recipients was also observed 
(Alencar et al. 1991). Moreover, amplification of parasite 
DNA from the germ line cells of infected human hosts 
and their descendants (Hecht et al. 2010) indicate that T. 
cruzi infections can be sexually transmitted.
Herein, we hypothesized that the endemicity of the 
infection in urban areas of Latin America, and its rec-
ognition to some extent in Africa, Asia, Europe, and 
Oceania (Schmunis & Yadon 2010, Albajar-Viñas & 
Jannin 2011, Pérez-Molina et al. 2012), in the absence of 
insect vectors and of other modes of the infection, can 
explained by sexual transmission of T. cruzi. To deter-
mine whether T. cruzi can be sexually transmitted in hu-
mans, we analysed four families with acute Chagas dis-
ease (ACD). Acute cases with fever, headache, malaise, 
generalised muscle pain, prostration, and occasional 
signs of heart trouble received medical care. We report a 
family-based study that reveals the sexual transmission 
of T. cruzi infection in humans.
SUBJECTS, MATERIALS AND METHODS
Ethics statement - The University of Brasilia Medi-
cal School Ethical Committee on Human Research ap-
proved the research protocol nº 2500.167567/2004-28. 
Additionally, the Ministry of Health National Commis-
sion on Human Research (CONEP Protocol nº 2585/04) 
in agreement with the National Health Council Resolu-
tion 196/1996 determined that all procedures complied 
with the Brazilian regulations and international guide-
lines. All adult subjects and all parents or guardians of 
child participants provided written informed consent on 
their behalf. The informed consent was signed by adults, 
parents, or guardians, before collecting blood samples, 
including positive and negative control samples. These 
anonymised serum bank samples were maintained at 
-20ºC. Semen samples were obtained from 23 adult vol-
unteers who signed the informed consent. The free con-
sent form for field studies carried out at the Counties of 
Barcarena and Breves was approved by the Ethical Com-
mittee of the Public Foundation Hospital Gaspar Vianna 
(protocol nº 054/2009) and by the CONEP/Ministry of 
Health (protocol nº 11163/2009) related to the study as 
described previously (protocol nº 2585/2004).
Experiments involving laboratory mice were approved 
by the Faculty of Medicine Ethical Committee on Animal 
Research under protocol nº 10411/2011 and were conduct-
ed in accordance with the National Council for the Con-
trol of Animal Experimentation, guiding line principles 
for biomedical research involving animals, and Council 
for International Organization of Medical Sciences and 
the International Council of Laboratory Animal Sciences.
Human study population - This short-run longitudi-
nal study included four families living in the counties of 
Barcarena and Breves, Pará state, Brazil. The subjects 
in this family study population comprised 47% females 
and 53% males ranging in age from 2 to 70 years. Micro-
scopic examination and haemoculture of the blood was 
conducted to detect T. cruzi infections. Of the volunteers 
in families A (15 individuals), B (44 individuals), C (29 
individuals), and D (21 individuals), chronic infections 
were detected by anti-T. cruzi IgG and by parasite nucle-
ar DNA (nDNA) from blood samples (Hecht et al. 2010) 
obtained at 1, 2, and 3 years after disease onset. Twen-
ty positive controls showed specific T. cruzi IgG and 
nDNA-positive results. Ten negative controls showed the 
absence of the antibody and nDNA. The research proto-
col and procedures complied with the Brazilian regula-
tions and international guidelines.
Parasite growth - The T. cruzi (Chagas 1909) isolate 
was obtained from Berenice’s blood 55 years after the 
acute phase of infection from Professor Egler Chiari, 
Institute of Biology of the Federal University of Minas 
Gerais, Brazil, and wild-type isolates obtained from the 
Evandro Chagas Institute (ECI-1 to ECI-21) were grown 
in the laboratory. Additionally, to confirm that our iso-
lates were T. cruzi, we used Leishmania braziliensis iso-
late H3227 from Dr Araujo and Dr Dourado, Institute of 
Biology of the University of Brasilia. The T. cruzi Ber-
enice and wild-type amastigotes and trypomastigotes 
were maintained in an L6 muscle cell line grown in Dul-
becco’s modified Eagle’s medium (DMEM) at pH 7.2 and 
supplemented with 10% foetal bovine serum, 100 IU/mL 
penicillin, 100 g/mL streptomycin, 250 nM L-glutamine, 
and 5% CO2 at 37ºC. The T. cruzi samples were cultured 
in blood agar in an axenic liver infusion tryptose medium 
at 27ºC. The L. braziliensis promastigotes were cultured 
in DMEM supplemented with 20% foetal bovine serum 
to harvest the parasitic forms during the exponential 
growth phase. The T. cruzi trypomastigotes in the super-
natants of the L6 murine cell cultures were used to infect 
mice and for microscopic examination to search blood 
trypomastigotes and solid tissue amastigote forms.
Fluorescence in situ hybridisation - Archetype Ber-
enice T. cruzi trypomastigotes and isolates from ACD 
cases were fixed onto slides before incubation with 
RNase I (100 µg/µL) for 1 h at 37ºC and then dehydrated 
with 70%, 90%, and 100% cold ethanol. The parasites 
were denatured in 50% formamide for 5 min at 92ºC 
immediately before use, and the 188-nucleotide (nt) 
probe for nuclear T. cruzi DNA was labelled (Molecular 
Probes, Invitrogen, Carlsbad, CA, USA). The probe (4 
ng/µL) was combined with hybridisation buffer supplied 
with the dye, denatured for 10 min at 72ºC in 50% for-
mamide in 2X SSC, kept on ice for 30 min, and placed 
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onto the slides. The 188-nt DNA probe (10 µL) was 
mixed with 70 µL of hybridisation buffer and applied to 
the specimen, and the slide was covered with a coverslip 
and placed in a humidified chamber at 37ºC overnight. 
The slide, which was washed for 30 s in 0.4X SSC/0.3% 
NP-40 at 73ºC, was placed in this solution for 2 min and 
again washed for 1 min at room temperature by 24ºC 
in 2X SSC/0.1 NP-40. The primary goat antibody to di-
goxigenin was identified with an FITC-labelled rabbit 
anti-goat IgG (Nordic), the slide was examined using 
an OLYMPUS BX51 light microscope (Tokyo, Japan) 
with DAPI and FITC filters, and images were collected 
simultaneously. Additionally, the genotype of the wild-
type isolate was determined using the T. cruzi Berenice 
188-nt digoxigenin-labelled probe, which identified 
anti-digoxigenin monoclonal antibody-labelled alkaline 
phosphatase (Molecular Probes). Colour detection was 
performed using the BCIP and NBT redox system to 
form a water-insoluble, dark blue precipitate (Teixeira et 
al. 2001, Mendes et al. 2007, Hecht et al. 2010).
Nuclear and kinetoplast DNA (kDNA) extraction 
and purification - DNA samples extracted from T. cruzi 
epimastigotes, L. braziliensis promastigotes, and from 
venous blood drawn from a cubital vein, and mono-
nuclear cells were separated using a Ficoll-Paque (GE 
Healthcare, Little Chalfont, UK) gradient (Mendes et al. 
2007, Hecht et al. 2010). Sperm samples were suspended 
immediately in DMEM (1:4 v/v), pH 7.4, and haploid 
cells collected from the supernatant were incubated for 
45 min at 5% CO2, 37ºC. Spermatozoa recovered from 
the supernatant were centrifuged at 13000 x g for 5 min 
and placed in extraction buffer (10 mM Tris-HCL, pH 
8.0, containing 10 mM NaCl, 20 mM EDTA, 1% SDS, 
0.04% proteinase-K, and 1% DTT) (Moser et al. 1989) 
prior to DNA extraction. T. cruzi kDNA was extracted 
as described previously (Hecht et al. 2010, Teixeira et 
al. 2011b). Three independent experiments using human 
DNA samples were conducted one year apart.
Primers and probes - The nDNA primers Tcz1/Tcz2 
and kDNA primers S35/S36 (Table) were used for poly-
merase chain reaction (PCR) amplification (Moser et al. 
1989, Sturm et al. 1989) as previously described (Hecht et 
al. 2010). The probes used in Southern blot hybridisation 
were: (1) nDNA repetitive sequence (188 bp) obtained by 
amplification of parasite DNA with the Tcz1/2 primers; 
(2) wild-type kDNA (∼1.4 kb) minicircle sequences puri-
fied from T. cruzi epimastigote forms (Hecht et al. 2010). 
The probes were purified from 1% agarose gels.
Southern blotting and PCR analyses - Genomic DNA 
from 109 subjects from four study families, 20 Chagas pa-
tients’ positive controls, and 10 uninfected controls were 
used as templates for PCR with specific T. cruzi nDNA 
Tcz1/2 (Moser et al. 1989) and kDNA primers s35/s36 
(Sturm et al. 1989). The standard PCR mixture contained 
100 ng template DNA, 0.4 µM of each pair of primers, 
2 U Taq DNA polymerase, 0.2 mM dNTPs, and 1.5 mM 
MgCl2 in a 25 µL final volume. The sensitivity of Tcz1/2 
primers was determined in a mix of 200 ng chicken DNA 
with serial dilutions of T. cruzi DNA (from 1 ng to 1 fg) 
and the standard procedure was carried out with the same 
concentrations of reagents used in the test experiments 
with human DNA alone (Hecht et al. 2010). The program 
used was 95ºC for 5 min, followed by 35 cycles at 95ºC/30 
s, 64ºC for 1 min, and at 72ºC for 3 min; the reaction was 
maintained at 72ºC for 5 min and products were stored at 
4ºC. The amplification products were analysed on a 1.3% 
agarose gel and transferred to a positively-charged nylon 
membrane (GE Life Sciences) using the alkaline method 
for hybridisation with specific probes labelled with [α-32P] 
dATP using Random Primer Labeling Kit (Invitrogen).
Southern hybridisations were conducted with EcoRI 
(Invitrogen) digests of DNA samples of blood mononu-
clear cells from uninfected controls, Chagas cases (posi-
tive controls), and 109 people belonging to four study 
families. The enzymes made single cuts in the T. cruzi 
kDNA minicircles, and the digests were subjected to 
electrophoresis in a 0.8% agarose gel at 50 V overnight 
at 4ºC. The gel transferred to a positively charged nylon 
membrane was hybridised with a radiolabelled kDNA 
or nDNA probe. The membrane was washed twice for 
15 min at 65ºC with 2X SSC and 0.1% SDS, twice for 
15 min at 65ºC each with 0.2X SSC and 0.1% SDS, and 
autoradiograph for variable periods of time.
Amplification of sequences of kDNA minicircles 
integrated into the human genome - A modified ther-
mal asymmetric interlaced-PCR (TAIL-PCR) method 
(Hecht et al. 2010) was used in which kDNA primers 
were combined with primer sets obtained after aligning 
chimera sequences (GenBank numbers AAF002199 to 
AF002203) within the Long Interspersed Nuclear Ele-
ment (LINE-1) retrotransposon of the human genome 
(Hecht et al. 2010). In the first round of amplification, 
each reaction included 200 ng template DNA, 2.5 mM 
MgCl2, 0.4 µM of kDNA primers (S34 or S67), 0.2 
mM dNTPs, and 2.5 U Taq Platinum (Invitrogen). The 
kDNA primers were used in combination with 0.04 µM 
of each LINE-1 (L1-1 to L1-6) primer (Table). Anneal-
ing temperatures ranged from 57.9-60.1ºC for kDNA 
primers, and from 59.9-65.6ºC for LINE-1 primer sets. 
These temperatures are higher than those (∼45ºC) re-
quired for the arbitrary degenerated primers used in 
TAIL-PCR (Hecht et al. 2010). The temperature and 
cycles used (MyCycle Thermocycler, Bio-Rad Labo-
ratories, Hercules, CA, USA) have been described 
previously (Hecht et al. 2010). In the second round of 
amplification, PCR products were diluted 1:40 (v/v) 
in water. The kDNA antisense primers S35 and S35 
were substituted for the nested primers, along with the 
same LINE-1 primers. In the third step, PCR products 
of tpTAIL-PCR 2 were diluted 1:10 (v/v) in water and 
the LINE-1 primers were combined in a reaction with 
either S67 antisense or S36. PCR products of the fi-
nal amplification that hybridised with the kDNA probe 
were cloned directly into the pGEM-T easy vector 
(Promega, Madison, WI, USA). Clones selected by hy-
bridisation with kDNA probe were sequenced commer-
cially. tpTAIL-PCR products were validated in a mix 
of 300 pg of kDNA from T. cruzi with 200 ng of DNA 
from control subjects who had never been exposed to 
kDNA. The temperature and amplification cycles were 
the same as those used for positive control DNA.
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Cloning, sequencing, bioinformatics, and statistical 
analysis - The PCR products that hybridised with the re-
petitive 188-nt T. cruzi nDNA and amplification products 
that hybridised with the kDNA probe were cloned directly 
into the pGEM T-Easy Vector (Promega). Clones selected 
by hybridisation with the nDNA and kDNA probe were 
sequenced commercially (Hecht et al. 2010). CLUSTALW 
was used for sequence analyses and alignments were per-
formed using BLAST. The expected scores (e-values) 
were recorded for determining statistical significance (p 
< 0.001). One-way analysis of variance was used for group 
analyses, while the Tukey test was employed to compare 
the means and standard deviations of the experimental 
data. A p < 0.05 indicated statistical significance.
Enzyme-linked immunosorbent assay (ELISA) - The 
enzyme-linked immunosorbent assay detected T. cruzi 
and L. braziliensis soluble antigens (1 µg/100 µL in 0.1 
M carbonate buffer, pH 9.6) on coated microplate wells 
(Mendes et al. 2007). The 1:100 human serum dilutions 
were incubated with the antigens for 2 h at room tem-
perature. After incubation, the plates were washed three 
times with phosphate-buffered saline (PBS)/Tween 20 
solution before drying, followed by a second incuba-
tion (50 μL of a 1:1000 dilution of alkaline phosphatase-
conjugated rabbit anti-human IgG, Zymed Laboratories, 
Inc., Carlsbad, San Francisco CA, USA). After incuba-
tion for 90 min at 37ºC, the substrate p-nitrophenyl phos-
phate was added and optical densities (OD) were read at 
630 nm in a multi-mode (Bio-Tek Synergy HT, Winoos-
ki, VT, USA) plate reader. The test and control sera as-
says were run in triplicate, and the OD results represent 
the means ± standard deviation (SD). A serum dilution 
yielding an absorbance of 0.150 or above was considered 
a positive reaction. This cut-off was used for bank serum 
samples. Three independent ELISA experiments were 
conducted for human serum samples obtained one year 
apart. For these serological assessments (CONEP pro-
tocol n° 2585/2004), we employed de-identified serum 
bank negative control samples and positive control se-
rum from Chagas patients with parasitological T. cruzi.
Indirect immunofluorescence test (IIF) - For IIF, 20 µL 
of human serum dilutions in PBS, pH 7.4, were incubated 
with glass slides that had been smeared with formalin-
killed epimastigotes of T. cruzi Berenice or promastigotes 
of L. braziliensis. After 1 h incubation in a moist cham-
ber at 37ºC, the slides were thoroughly washed twice with 
PBS, air-dried, and treated with a fluorescein-labelled anti-
Ig (Zymed Laboratories, Inc., Carlsbad, San Francisco CA, 
USA). A positive apple-green reaction under the OLYM-
PUS BX51 microscope with an FITC filter indicated a 
positive sample in 1:40 and above human serum dilutions 
(Mendes et al. 2007). IIF assays examined in triplicate in 
human serum samples obtained one year apart.
Infection of mice with T. cruzi from Chagas patient 
semen - BALB/c mice were originally from the Jack-
son Laboratory (Bar Harbor, ME, USA) and purchased 
from the Animal Facilities of the Ribeirão Preto Medical 
School of São Paulo University. The 12 mice used in these 
experiments were maintained under positive air pressure 
at 24ºC and fed Purina chow and water ad libitum in our 
animal room. Aliquots (100 µL) of fresh semen samples 
from 18-year-old nDNA-positive chronic Chagas patients 
were intraperitoneally inoculated into three 1-month-old 
naïve, uninfected, BALB/c mice. Additionally, aliquots of 
semen (total 100 µL) were infused through a pipette tip 
into the vagina of three age-matched BALB/c mice. In the 
control experiments, an equal number of uninfected, one-
month-old males were inoculated intraperitoneally with 
semen from a 20-year-old, nDNA-negative individual, 
and three females received aliquots of the semen infused 
into the vagina. Five weeks later, all mice were sacrificed 
under anaesthesia, and the tissues were fixed in formalin 
and embedded in paraffin. Serial tissues sections (4-µM 
thick) were stained with haematoxylin-eosin (H-E).
TABLE
Primers used in the polymerase chain reactions
Primers DNA template Sequences
S35 kDNA 5’- ATA ATG TAC GGG (T/G)GA GAT GC -3’
S36 kDNA 5’- GGT TCG ATT GGG GTT GGT G-3’
S34 kDNA 5’- ACA CCA ACC CCA ATC GAA CC- 3’
S67 kDNA 5’- GGTTTTGGGAGGGG(G/C(G/C)(T/G)TC-3’
S35 reverse kDNA 5’- GCA TCT CMC CCG TAC ATT AT -3’
S67 reverse kDNA 5’- GAM (G/C(G/C)C CCC TCC CAA AAC C- 3’
L1-1 LINE-1 5’- CTC CGG TCT ACA GTC CCC A- 3’
L1-2 LINE-1 5’- CTC CCA AGA CTA AAC CAG GA- 3’
L1-3 LINE-1 5’- ATC ACA CTC TGG GGA CTG TG- 3’
L1-4 LINE-1 5’- CAC AGT CCC CAG AGT GTG AT- 3’
L1-5 LINE-1 5’- TCC TGG TTT AGT CTT GGG AG- 3’
L16 LINE-1 5’- TGG GAG CTG TAG ACC GGA G- 3’
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RESULTS
In recent decades, physicians in the Brazilian Ama-
zonia (Teixeira et al. 2001, Coura et al. 2002) have faced 
ACD epidemics. The ACD outbreaks that occurred 
during 2007 and 2009, with oligosymptomatic cases of 
acute T. cruzi infection, received medical assistance at 
Gaspar Vianna General Hospital, Belém, Brazil. The 
ACD patients and their family members volunteered to 
participate in the research study, which was approved 
by the ethics committee. These patients from four fami-
lies lived beside tributaries to the Amazon River in the 
counties of Barcarena and Breves in the state of Pará, 
Brazil. Venous blood samples analysed by direct micro-
scopic examination and in vitro culture revealed parasite 
growth. In these families, 21 subjects with some clini-
cal signs and symptoms of acute infection contained the 
haemoflagellate protozoan in blood cultures as detected 
at the Evandro Chagas Institute (ECI). Isolates of wild-
type protozoa (ECI-1 to ECI-21) were used to infect L6 
murine muscle cells and the flagellates that entered the 
host cells readily appeared as round amastigotes, which 
continually divided, swarmed the host cells, and burst 
out into free-swimming trypomastigotes in supernatant 
medium. Next, 1 × 105 trypomastigotes from the tissue 
culture supernatant were injected into the peritoneal 
cavity of mice, and the parasite was detected in the tail 
blood two weeks later. To further characterise the wild-
type protozoan isolates, we subjected the tissue culture 
trypomastigotes to phenotyping. We used standard an-
tiserum IgG from a Chagas disease case with parasito-
logical demonstration of the haemoflagellate T. cruzi. 
The archetype T. cruzi Berenice trypomastigote was a 
specific target for the Chagas antibody, and the promas-
tigote of its family related to L. braziliensis, an agent 
of cutaneous leishmaniasis, was the negative control 
(Mendes et al. 2007). We consistently identified ECI-1 
to ECI-21 isolates as wild-type T. cruzi (Fig. 1).
In this series, each acute infection case received the 
anti-trypanosome nitro-derivative benznidazole (5 mg/
kg of body weight for 60 days per os). Human DNA 
extracted from blood mononuclear cells collected at 1, 
2, and 3 years was assessed for the presence of T. cruzi 
nDNA and symbiotic mitochondrion kDNA (Moser et 
al. 1989, Sturm et al. 1989, Hecht et al. 2010). kDNA, 
comprising ~30% of the total cellular DNA, contains ap-
proximately 20,000 minicircles and a few dozen max-
icircles. The T. cruzi initiates replication signalling in 
the symbiotic kinetoplast by relaxation of the minicircle 
network, which precedes nDNA whole cell division. De-
spite the critical role of the kinetoplast network in para-
site replication, its loss does not result in immediate cell 
death (Schnaufer et al. 2002). Therefore, demonstration 
of the nDNA footprint is a unique, essential requirement 
for the diagnosis of active T. cruzi infection.
Thus, we probed the DNA collected at three time 
point from the 21 acutely infected cases using Tc1/2 
primer sets that amplify a highly specific repetitive 
species comprising 7% of total T. cruzi nDNA (Moser 
et al. 1989). We detected protozoan nDNA amplicons 
in the family members of the ACD cases (Fig. 2A) as-
sessed by three independent experiments conducted 
with samples obtained one year apart. These amplicons 
Fig. 1: the phenotype of the Trypanosoma cruzi isolates from acutely infected humans. The Berenice protozoan flagellate and the ECI-4 wild-
type flagellate shown by bright field (BF) imaging and DAPI (4’, 6-diamidino-2-phenylindole) used to stain parasite kinetoplast (kDNA) and 
nucleus (nDNA) in blue. These parasite isolates identified with the specific Chagas antiserum IgG that recognizes T. cruzi Berenice, ECI-4, 
but it does not recognize Leishmania braziliensis promastigotes after treatment with an FITC-labeled monoclonal antibody to human IgG. The 
insets show the negative controls. Bars, 20 µM.
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Fig. 2: the Trypanosoma cruzi genotype identified in the haemo flagellates from the acute Chagas disease cases. (A) The T. cruzi infections 
identified by the PCR nDNA footprints formed 188 nt bands and catamers after Southern blot with the specific radiolabeled probe; (B) the EC1-4 
flagellate identified by the nDNA footprints. The wild-type T. cruzi shown by hybridisation with the digoxigenin-labeled 188 nt nDNA probe. 
From left to right: bright field image; the T. cruzi trypomastigote green DNA visible with a primary IgG to the digoxigenin-labeled 188 nt probe 
after interaction with a secondary fluorescent antibody; and, merge of previous images. The inserts show negative controls; (C) the ECI-10 
trypomastigote shown by hybridisation with the Berenice T. cruzi 188 nt digoxigenin-labeled probe. The EC1-13 isolate shows a dark nucleus 
stained with an alkaline phosphatase-labeled monoclonal Ab to digoxigenin. Tc, T. cruzi; nc, negative control.
hybridised with the specific radiolabelled 188-nt se-
quence probe; cloning and sequencing showed that each 
T. cruzi amplicon had the unique 188-nt nuclear repeat 
motif sequence (Moser et al. 1989). Additionally, pro-
tozoan kDNA amplified with primer sets (Sturm et al. 
1989) was annealed to minicircle sequences from each 
of the 21 ACD cases. These results were validated by 
genotype analysis, whereby a digoxigenin-labelled T. 
cruzi Berenice 188-nt nDNA sequence probe identified 
homologous repeats in wild-type isolates, which was 
visualised with a fluorescein-conjugated monoclonal 
antibody against digoxigenin (Fig. 2B). The specificity 
of these hybridisation procedures was verified in the 
negative control L. braziliensis promastigotes. An al-
kaline phosphatase-conjugated monoclonal antibody to 
the digoxigenin-labelled probe revealed further hybridi-
sation of the digoxigenin-labelled 188-nt sequence with 
homologous repeats (Moser et al. 1989) in the genomes 
of wild-type isolates (Fig. 2C). These results show that 
haemoflagellates in the ACD patients were wild-type T. 
cruzi. The specific 188-bp sequence was present in 20 
positive controls and absent in negative controls. Thus, 
the specific T. cruzi nDNA (188-bp) band detected in the 
21 benznidazole-treated ACD cases (Fig. 2A) directly 
demonstrated persistent, chronic infection.
The sensitivity of PCR for nDNA with the Tcz1/2 
primer set reached 10 fg, which is 1/24 of the total nDNA 
(240 fg) from a diploid trypomastigote (Hecht et al. 2010). 
To evaluate the ratios of T. cruzi chronic infections in the 
study population, we employed the nucleic acid test, which 
showed high specificity and sensitivity for parasite nDNA 
footprints in volunteers from the four study families. The 
specificity and sensitivity of the assay revealed that PCR 
can be used for high-quality diagnosis of congenital infec-
tions and assessment of drug efficacy in Chagas disease 
chemotherapy (Britto 2009). In these PCR assays, the am-
plification products that hybridised with the specific ra-
diolabelled 188-nt probe (Moser et al. 1989) formed nDNA 
bands in 76% (83/109) of the tested samples. Furthermore, 
the kDNA amplification products formed bands in 92.5% 
of samples (101/109) tested with specific primer sets 
(Mendes et al. 2007, Hecht et al. 2010). The results of these 
experiments are shown in Fig. 3.
The ELISA and IIF tests detect serum T. cruzi an-
tibodies (Mendes et al. 2007). These assessments con-
sistently detected specific T. cruzi antibodies in 28.4% 
(31/109) of the study population. Eight individuals 
(7.4%) remained free of T. cruzi antibodies, nDNA, and 
kDNA. The plots of ODs obtained from the ELISAs for 
the 109 individuals and serum-bank positive and nega-
tive controls are shown in (Fig. 4A). The negative and 
positive control, respectively, group I and II serum dilu-
tions revealed optical density (ODs) low readings sig-
nificantly different (p < 0.05) from those high readings 
of the test group III for breaking open in subgroups IIId 
to IIIa (Fig. 4A). Thus, there were broad discrepancies 
between the presence of specific T. cruzi antibodies and 
PCR test results: 37.4% (31/83) of patients yielded both 
positive nucleic acids and specific antibody assays (III-
a), whereas 62.6% (52/83) showed nDNA+ and kDNA+ 
bands in the absence of specific antibodies (III-b). Eigh-
teen subjects (16.5%) showed integrated kDNA alone 
(III-c), while eight people (7.4%) had none (III-d).
The 1960 Nobel Prize winners, Sir Frank McFarlane 
Burnet and Peter Brian Medawar explained that differ-
ence depending on the immune tolerance acquisition 
during early embryo with immature immune system.
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Fig. 3: demonstration of the Trypanosoma cruzi nuclear DNA and of its mitochondrial kDNA by Southern blot with the specific radio labeled 
probes. Family A - T. cruzi infections in 15 people, showing positive nDNA and kDNA bands. Family B - In this family, 35 out of and 43 subjects 
formed the nDNA and kDNA bands. The individual 25 had the kDNA band alone. Family C - Among 29 members of the family C, 22 formed 
the nDNA and the kDNA bands and five had the kDNA alone. Family D - Eleven out of 21 subjects of the family D formed the nDNA and the 
kDNA bands; additionally, 10 subjects had the kDNA band alone.
To clarify this point, we isolated T. cruzi nDNA from 
the germ cell line of subjects at their reproductive ages. 
Haploid DNA revealed T. cruzi nDNA+- and kDNA+-
specific bands in 19 of 23 (82.6%) semen samples (Fig. 
4B). Additionally, the infectivity of T. cruzi from a Chagas 
patient’s ejaculate, which tested positive in nDNA assays 
and lacked specific antibodies, was demonstrated by in-
jecting 100 µL of semen into the peritoneal cavity of male 
mice and through infusion of an equal amount of semen 
into the vagina of 1-month-old female BALB/c mice. Five 
weeks later, we detected T. cruzi amastigote nests in the 
heart and skeletal muscles, and clumps of differentiating 
parasites were present in the lumen of the vas deferens 
and uterine tube (Fig. 4C). These markers were not detect-
ed in control mice that received nDNA-negative semen.
Heredograms with personalised profiles enabled rapid 
visualisation of study family data. Fig. 5 shows family 
subjects with infections in the presence of both IgG anti 
T. cruzi and its nDNA and infections in the absence of IgG 
but in the presence of parasite nDNA. Additionally, 18 sub-
jects (16.5%) without active T. cruzi infection contained 
kDNA minicircle alone integrated into the human genome. 
This finding can be explained by the insertion of mutations 
into specific loci in the human genome (EMBL HG008116 
to HG008708) either through active T. cruzi-infection or 
through kDNA inheritance from the parents (Hecht et al. 
2010, Teixeira et al. 2011b, Guimaro et al. 2014).
DISCUSSION
In this study, we present epidemiological, clinical, para-
sitological, immunological, and nucleic acid data indicating 
that human T. cruzi infections can be sexually transmitted. 
We assessed active T. cruzi infections in the somatic and in 
the germ cell line of individuals in a family study popula-
tion. We documented the parasite nDNA footprints in the 
blood nucleated cells and in the haploid cells of the semen 
ejaculates, as well as in the absence of the specific T. cruzi 
antibody in the serum of the chagasic patients.
The parasitological demonstration of the protozoan 
in 21 ACD cases was fundamental to our covalidation of 
the PCR nDNA footprints, which formed specific 188-nt 
bands in the samples from T. cruzi-infected subjects only. 
The diagnosis made using this standard laboratory assay 
was compared with the results of specific immunological 
tests. The broad differences between the ratios of positive 
results obtained with parasite-specific antibodies (37.4%) 
and those with nDNA tests (62.6%) indicated that most 
cases, in the absence of specific antibodies, stem from 
sexually transmitted T. cruzi infections during embryo 
development before maturation of the immune system. 
This agrees with the demonstration of T. cruzi nDNA 
footprints in the semen of 19 of 23 chagasic males in the 
absence of specific serum antibodies in the study families.
The symbiotic kDNA is a landmark of the kineto-
plastid protozoan, but the PCR assay with the symbiont 
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Fig. 5: heredograms and personalised profiles of the Trypanosoma 
cruzi infections in four study families. Family A - of the 15 mem-
bers tested, four had the T. cruzi IgG antibody, nDNA and kDNA; 11 
had the parasite nDNA and kDNA, and five (yellow numbers) had T. 
cruzi in their ejaculates. Family B - of the 44 samples, 11 had the T. 
cruzi IgG antibody, nDNA and kDNA and 23 had the parasite nDNA 
and kDNA footprints in the absence of antibody. In this family, T. 
cruzi nDNA found in the ejaculates of seven subjects: three members 
had kDNA alone integrated into the genome, and seven had none of 
the above (numbered white circles and squares). Family C: - of the 
29 members tested, five had the T. cruzi IgG antibody, nDNA and 
kDNA, 17 had the parasite nDNA and kDNA footprints, six had inte-
grated kDNA only and one patient had none of the above. In this fam-
ily four members had the T. cruzi active infections (yellow numbers) 
in the ejaculates; Family D: - of the 21 subjects tested, 11 had the T. 
cruzi IgG, nDNA and kDNA; one had the nDNA and kDNA, nine 
members had integrated kDNA only; two subjects (92 and 95) had the 
T. cruzi active infections in the ejaculates.
DNA primer sets (Sturm et al. 1989) should not be used 
to diagnose Chagas disease because the kDNA sequence 
alone integrates into the host genome and is inherited 
by the progeny (Hecht et al. 2010, Teixeira et al. 2011b, 
Guimaro et al. 2014); we detected the T. cruzi kDNA 
minicircle sequences alone integrated into the host ge-
nome in 16.5% (18/109) of family members without 
active infection. However, these findings suggest a po-
tential for the development of genetically driven inflam-
matory lesions, and the immune tolerance status was 
correlated with the outcome of autoimmune disease over 
time (Teixeira et al. 2011b, Guimaro et al. 2014).
Immune tolerance in chickens hatched from T. cruzi-
inoculated eggs in the absence of the specific antibody 
was observed after challenge with the formalin-killed 
flagellate (Guimaro et al. 2014). Herein, tolerance is 
a natural phenomenon resulting from altered immune 
system immunoglobulin expression and abrogation of 
the functional signalling of self-reactive B lymphocytes 
(Poncini et al. 2008), which explains the absence of the 
specific T. cruzi antibody in patients with the nDNA-pos-
itive 188-nt band (Hecht et al. 2010). Additionally, im-
munologic self-tolerance in T. cruzi infections is associ-
ated with regulatory dendritic cells in vitro (Poncini et al. 
Fig. 4: the Trypanosoma cruzi infections demonstrated in the study fam-
ilies. (A) Profiles of T. cruzi infections shown by the specific antibody 
and by the nDNA footprints. Group I (n = 10) and group II (n = 20) were, 
respectively, the negative and the positive control antiserum to T. cruzi 
infections. Group III split subgroups: III-a (n = 31) families’ cases with 
the infections confirmed by nDNA-positive and specific antibodies to 
T. cruzi; III-b (n = 52) included families with the infections detected by 
the T. cruzi nDNA-positive in the absence of specific antibodies; III-c (n 
= 18) included families displaying kDNA-positive only in the absence 
of nDNA and of specific antibodies; III-d (n = 8) included the study 
population individuals with all tests negative. (B) Profiles of the nDNA 
and kDNA present in the germ cell line. Nineteen out of 23 semen 
samples contained the T. cruzi infections shown by the positive nDNA 
and kDNA assays. Tc, T. cruzi; nc, negative control. (C) The infectivity 
of the T. cruzi from human ejaculate inoculated in mice. Left, T. cruzi 
amastigotes nest in the heart (top) and in the lumen of the vas deferens 
(bottom). Right, T. cruzi amastigotes nest in the skeletal muscle (top) 
and in the uterine tube (bottom). The insert shows a dividing amastigote 
(circle). Bars, 25 µM. Arrows show amastigote parasites.
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2008); tolerance was maintained by CD25+/CD25+ fox3-
positive T cells (Belkaid 2008) expressing IL-2 receptors 
α-chains (Sakaguchi et al. 1995). The development of full 
tolerance requires T. cruzi infection at an early embryo 
age with an immature immune system, which recognises 
the parasite thereafter as a component of its own body 
(Teixeira et al. 2011b, Guimaro et al. 2014).
Interestingly, infusions into the vagina or intraperitone-
al inoculation of the semen from Chagas patients showing 
the nDNA footprint, but without the specific T. cruzi anti-
body, generated nests of T. cruzi amastigotes in the heart, 
skeletal muscles, vas deferens, and uterine tube of mice five 
weeks later. The T. cruzi amastigote clumps and transform-
ing trypomastigote detected in reproductive organs, which 
were confirmed by immunoperoxidase assays.
Furthermore, in a mouse model system, da Silva (2013) 
found that T. cruzi infections were transmitted to naïve 
mates during intercourse. These experiments showed 
that healthy, control female or male mice that sexually 
mated with a T. cruzi-infected male or female acquired 
the flagellate. Crossbreeding of males or females showing 
the nDNA footprints to naïve females or males generated 
progeny with active T. cruzi infections. Breeding of T. 
cruzi-infected mice with naïve mates generated progeny 
showing nDNA footprints in 58.6% (41/70) of samples ex-
amined, but the specific antibodies were present in as few 
as 22% (9/40) of mice progeny (da Silva 2013). Further-
more, nests of T. cruzi amastigotes were documented in 
the reproductive organs of the progeny.
The experimental findings in the mouse model indi-
cate that T. cruzi can be sexually transmitted in humans. 
Moreover, in the absence of a demonstrable port of entry 
of exogenous T. cruzi, either through the skin or other 
route of infection, we conclude that a minority of Chagas 
family members showed the specific antibody because 
the sexually transmitted infectious agent reached a foe-
tus with a mature immune system. The T. cruzi-infected 
females and males sexually transmit the infectious agent 
to uninfected, naïve mates during intercourse and, addi-
tionally, the progeny retain active infection in the semen 
or uterine secretions into the vagina (da Silva 2013).
The potential epidemiologic dispersion of infections 
by the sexual route correlates with the persistence of T. 
cruzi forms in the male and female organs of reproduc-
tion. In this study, clumps of replicative T. cruzi forms in 
the sexual organs of mice associated local immune privi-
lege as described elsewhere (Wood & Sakaguchi 2003, 
Niederkorn 2006, Fujisak et al. 2011), thus explaining 
why the sexual transmission is common. The observed 
ratios of sexual transmission of T. cruzi infections may 
require reproduction systems to achieve sustainable im-
mune privilege that bolsters parasite growth. The im-
mune privilege described for the testicles, uterus, tubes, 
and ovary may explain the uncurbed growth of T. cruzi in 
reproductive organs (Bonomo & Savino 2015) such that 
the parasite can reach a sexual partner through uterine 
secretions and ejaculates. Immune privilege is a phenom-
enon that allows some organs (testes, uterus, eyes, and 
brain) to down-regulate inflammatory reactions to avoid 
damage to sensitive and specific functions (Wood & 
Sakaguchi 2003, Niederkorn 2006). Hormones (Fujisak 
et al. 2011) and several immune factors down-regulate 
macrophages, natural killer cells, T lymphocytes, and 
regulatory Treg cells, thus orchestrating the inhibition of 
some pro-inflammatory cytokines and immune privilege 
triggers (Wood & Sakaguchi 2003, Fujisak et al. 2011). 
Moreover, this study showed that T. cruzi has a unique 
survival capability, such that it continuously adapts to a 
non-hostile environment from which it can escape before 
the host dies. In this regard, T. cruzi is a sexually trans-
mitted mutagenic agent that promotes evolution, descen-
dants with modifications, and natural selection (Hecht et 
al. 2010, Teixeira et al. 2011b, Guimaro et al. 2014).
In conclusion, examination of chagasic families en-
abled us to combine clinical with experimental data to 
reveal the sexual transmission of T. cruzi infections. 
Thus, the dispersion of human Chagas disease to five 
continents (Schmunis & Yadon 2010, Albajar-Viñas & 
Jannin 2011, Pérez-Molina et al. 2012) is possible. Addi-
tional studies needed to clarify whether Chagas disease-
free parallels socially equal popopulation, and Chagas 
disease would never threaten this far (Hotez et al. 2012).
Further family studies are needed to map the preva-
lence of T. cruzi infections, likely acquired sexually and 
through various other routes, by human populations in 
different ecosystems. Moreover, the development of a 
drug without genotoxic effects is essential to eradicate 
T. cruzi infections and prevent Chagas disease.
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